ArticleHarm reduction journal2012
Prescribing cannabis for harm reduction.
Article in Harm reduction journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 82 citations in OpenAlex.
- Cannabis donation as a harm reduction strategy: a case study.Harm reduction journal · 2024Article
- A Pragmatic, Person-Centered View of Cannabis in the United States: Pursuing Care That Transcends Beliefs.Substance abuse · 2023Review
- To Treat or Not to Treat? Polish Physicians' Opinions about the Clinical Aspects of Cannabinoids-An Online Survey.Journal of clinical medicine · 2022Article
- Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample.Harm reduction journal · 2021Article
- Article
- Opioid Misuse and the Availability of Medical Marijuana Through Dispensaries.Journal of studies on alcohol and drugs · 2020Article
- Cannabidiol in Anxiety and Sleep: A Large Case Series.The Permanente journal · 2019Article
- Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.The journal of headache and pain · 2018Article
- A user's guide to cannabinoid therapies in oncology.Current oncology (Toronto, Ont.) · 2016Review
- A safer alternative: Cannabis substitution as harm reduction.Drug and alcohol review · 2015Article
- Medical marijuana programs - Why might they matter for public health and why should we better understand their impacts?Preventive medicine reports · 2015Article
- Marijuana: current concepts(†).Frontiers in public health · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuropathic pain affects between 5% and 10% of the US population and can be refractory to treatment. Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for treating nerve pain without the risk of fatal poisoning. The author suggests that physicians who treat neuropathic pain with opioids should evaluate their patients for a trial of cannabis and prescribe it when appropriate prior to using opioids. This harm reduction strategy may reduce the morbidity and mortality rates associated with prescription pain medications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.